Targeting the Sarcomere: Myosin Inhibitors as the Revolutionary Game Changer in Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy (HCM) represents the most common inherited cardiac disease and a leading cause of heart failure, arrhythmias, and sudden cardiac death in young individuals. For decades, management of HCM has relied on symptom control with β-blockers, calcium channel blockers, disopyramid...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
IMR Press
2026-01-01
|
| Col·lecció: | Reviews in Cardiovascular Medicine |
| Matèries: | |
| Accés en línia: | https://www.imrpress.com/journal/RCM/27/1/10.31083/RCM47341 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|